Interpace OTC Stock Performance


USD 1.65  0.15  10.00%   

The company retains a Market Volatility (i.e., Beta) of 0.7015, which attests to possible diversification benefits within a given portfolio. Let's try to break down what Interpace's beta means in this case. As returns on the market increase, Interpace Diag returns are expected to increase less than the market. However, during the bear market, the loss on holding Interpace Diag will be expected to be smaller as well. Although it is important to respect Interpace Diag Group current price history, it is better to be realistic regarding the information on the equity's current price movements. The philosophy towards determining future performance of any stock is to evaluate the business as a whole together with its past performance, including all available fundamental and technical indicators. By evaluating Interpace Diag Group technical indicators, you can presently evaluate if the expected return of 0.0657% will be sustainable into the future. Interpace Diag Group right now retains a risk of 8.14%. Please check out Interpace Diag information ratio, potential upside, as well as the relationship between the Potential Upside and kurtosis to decide if Interpace Diag will be following its current trending patterns.
Interpace Performance
0 of 100
Over the last 90 days Interpace Diag Group has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of rather sound basic indicators, Interpace Diag is not utilizing all of its potentials. The latest stock price tumult, may contribute to shorter-term losses for the shareholders. ...more

Interpace Price Channel

Quick Ratio0.45
Fifty Two Week Low1.0500
Fifty Two Week High9.0000

Interpace Diag Relative Risk vs. Return Landscape

If you would invest  193.00  in Interpace Diag Group on August 28, 2022 and sell it today you would lose (28.00)  from holding Interpace Diag Group or give up 14.51% of portfolio value over 90 days. Interpace Diag Group is currently generating 0.0657% in daily expected returns and assumes 8.1447% risk (volatility on return distribution) over the 90 days horizon. In different words, 70% of otc stocks are less volatile than Interpace, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon.
  Daily Expected Return (%)  
       Risk (%)  
Given the investment horizon of 90 days Interpace Diag is expected to generate 1.78 times less return on investment than the market. In addition to that, the company is 5.88 times more volatile than its market benchmark. It trades about 0.01 of its total potential returns per unit of risk. The DOW is currently generating roughly 0.08 per unit of volatility.

Interpace Diag Market Risk Analysis

Today, many novice investors tend to focus exclusively on investment returns with little concern for Interpace Diag's investment risk. Standard deviation is the most common way to measure market volatility of otc stocks, such as Interpace Diag Group, and traders can use it to determine the average amount a Interpace Diag's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.

Sharpe Ratio = 0.0081

Good Returns
Average Returns
Small Returns
Negative Returns
Estimated Market Risk
  actual daily
 70 %
of total potential
Expected Return
  actual daily
 1 %
of total potential
Risk-Adjusted Return
  actual daily
 0 %
of total potential
Based on monthly moving average Interpace Diag is performing at about 0% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Interpace Diag by adding it to a well-diversified portfolio.

About Interpace Diag Performance

To evaluate Interpace Diag Group OTC Stock as a possible investment, you need to clearly understand its upside potential, downside risk, and overall future performance outlook. You may be satisfied when Interpace Diag generates a 15% return over the last few months, but what if the market is generating 25% over the same period? In this case, it makes sense to compare Interpace OTC Stock's performance with different market indexes, such as the Dow or NASDAQ Composite. These indexes can act as benchmarks that will help you to understand Interpace Diag Group market performance in a much more refined way. The Macroaxis performance score is an integer between 0 and 100 that represents Interpace's market performance from a risk-adjusted return perspective. Generally speaking, the higher the score, the better is overall performance as compared to other investors. The score is normalized against the average investing universe (the best we can interpret from the data available). Within this methodology, scores of individual equity instruments will always be inferior to the scores of portfolios of equities as portfolios typically diversify a lot of unsystematic risks away. The formula to derive the Macroaxis score bases on multiple unequally-weighted factors. For more information, refer to our portfolio performance evaluation section.
Please also refer to our technical analysis and fundamental analysis pages.
Last ReportedProjected for 2022
Return on Investment(80.88) (87.27) 
Return on Average Assets(52.32) (53.69) 
Return on Average Equity(85.22) (91.95) 
Return on Invested Capital(1.37) (1.48) 
Return on Sales(0.37) (0.39) 

Things to note about Interpace Diag Group

Checking the ongoing alerts about Interpace Diag for important developments is a great way to find new opportunities for your next move. OTC Stock alerts and notifications screener for Interpace Diag Group help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.

Interpace Diag Alerts

Equity Alerts and Improvement Suggestions

Interpace Diag Group has very high historical volatility over the last 90 days
Interpace Diag Group may become a speculative penny stock
Interpace Diag Group has a very high chance of going through financial distress in the upcoming years
The company currently holds 16.03 M in liabilities with Debt to Equity (D/E) ratio of 6.55, indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. Interpace Diag Group has a current ratio of 0.6, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Debt can assist Interpace Diag until it has trouble settling it off, either with new capital or with free cash flow. So, Interpace Diag's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Interpace Diag Group sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Interpace to invest in growth at high rates of return. When we think about Interpace Diag's use of debt, we should always consider it together with cash and equity.
The entity reported the previous year's revenue of 40.05 M. Net Loss for the year was (13.29 M) with profit before overhead, payroll, taxes, and interest of 17.95 M.
Interpace Diag Group currently holds about 1.86 M in cash with (6.07 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.44.
Interpace Diag Group has a poor financial position based on the latest SEC disclosures
Roughly 28.0% of Interpace Diag shares are held by company insiders
Latest headline from Interpace Biosciences Announces Third Quarter 2022 Financial and Business Results Sale of Pharma Significantly Improves Liquidity Resulting in Removal of Going Concern - Yahoo Finance
Please see Risk vs Return Analysis. You can also try Pair Correlation module to compare performance and examine fundamental relationship between any two equity instruments.

Complementary Tools for analysis

When running Interpace Diag Group price analysis, check to measure Interpace Diag's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Interpace Diag is operating at the current time. Most of Interpace Diag's value examination focuses on studying past and present price action to predict the probability of Interpace Diag's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Interpace Diag's price. Additionally, you may evaluate how the addition of Interpace Diag to your portfolios can decrease your overall portfolio volatility.
Equity Valuation
Check real value of public entities based on technical and fundamental data
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Analyst Recommendations
Analyst recommendations and target price estimates broken down by several categories
Bond Directory
Find actively traded corporate debentures issued by US companies
Price Transformation
Use Price Transformation models to analyze depth of different equity instruments across global markets
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Please note, there is a significant difference between Interpace Diag's value and its price as these two are different measures arrived at by different means. Investors typically determine Interpace Diag value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Interpace Diag's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.